Pharmacokinetic and Clinical Outcomes When Ideal Body Weight is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients

MLA

Shawn Griffin, et al. “Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients.” Biology of Blood and Marrow Transplantation, vol. 23, Mar. 2017, p. S394. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.12.612.

APA

Shawn Griffin, Ashley Richards, Laura Wiggins, & Sarah Wheeler. (2017). Pharmacokinetic and Clinical Outcomes When Ideal Body Weight is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation, 23, S394. https://doi.org/10.1016/j.bbmt.2016.12.612

Chicago

Shawn Griffin, Ashley Richards, Laura Wiggins, and Sarah Wheeler. 2017. “Pharmacokinetic and Clinical Outcomes When Ideal Body Weight Is Used to Dose Busulfan in Obese Hematopoietic Stem Cell Transplant Recipients.” Biology of Blood and Marrow Transplantation 23 (March): S394. doi:10.1016/j.bbmt.2016.12.612.